Florine A. Eggink

Groningen, GR, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Spatiotemporal Immune Landscape and Long-term Immune Memory in POLE-Mutant Endometrial Cancer at the Single-Cell Level.

Spatiotemporal Immune Landscape and Long-term Immune Memory in POLE-Mutant Endometrial Cancer at the Single-Cell Level.

Journal: Cancer immunology research

Published: January 23, 2025

Deep immune profiling of ovarian tumors identifies minimal MHC-I expression after neoadjuvant chemotherapy as negatively associated with T-cell-dependent outcome.

Deep immune profiling of ovarian tumors identifies minimal MHC-I expression after neoadjuvant chemotherapy as negatively associated with T-cell-dependent outcome.

Journal: Oncoimmunology

Published: September 14, 2020

Impact of different adjuvant treatment approaches on survival in stage III endometrial cancer: A population-based study.

Impact of different adjuvant treatment approaches on survival in stage III endometrial cancer: A population-based study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 18, 2020

A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer.

A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer.

Journal: Cancer immunology research

Published: July 30, 2018

Implementation of laparoscopic hysterectomy for endometrial cancer over the past decade.

Implementation of laparoscopic hysterectomy for endometrial cancer over the past decade.

Journal: Gynecological surgery

Published: November 09, 2017

Corrigendum to "Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratification" [Eur J Cancer 78 (2017) 82-90].

Corrigendum to "Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratification" [Eur J Cancer 78 (2017) 82-90].

Journal: European journal of cancer (Oxford, England : 1990)

Published: August 29, 2017

Surgery for patients with newly diagnosed advanced ovarian cancer: which patient, when and extent?

Surgery for patients with newly diagnosed advanced ovarian cancer: which patient, when and extent?

Journal: Current opinion in oncology

Published: June 15, 2017

Compliance with adjuvant treatment guidelines in endometrial cancer: room for improvement in high risk patients.

Compliance with adjuvant treatment guidelines in endometrial cancer: room for improvement in high risk patients.

Journal: Gynecologic oncology

Published: March 15, 2017

Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratification.

Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratification.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 06, 2017

The impact of centralization of services on treatment delay in ovarian cancer: A study on process quality.

The impact of centralization of services on treatment delay in ovarian cancer: A study on process quality.

Journal: International journal for quality in health care : journal of the International Society for Quality in Health Care

Published: December 20, 2016

Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition.

Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition.

Journal: Oncoimmunology

Published: October 12, 2016

CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy.

CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy.

Journal: Oncotarget

Published: May 06, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026